Pfizer, Flagship Pioneering to Target Obesity Treatments Under 2023 Partnership
BioSpace
JUNE 12, 2024
Building on last year’s potential $7 billion partnership with Flagship Pioneering, Pfizer and Flagship-founded ProFound Therapeutics will work on discovering new obesity candidates.
Let's personalize your content